A New Era in Emergency Allergy Treatment
Anaphylaxis is a life-threatening allergic reaction that can occur within minutes of exposure to allergens such as foods, insect stings, or medications. Until now, adrenaline auto-injectors (AAIs) like EpiPen have been the only emergency treatment option. But for many, needle anxiety or uncertainty about how to use an injector can cause dangerous delays.
What’s New?
The UK’s first needle-free adrenaline nasal spray—EURneffy®—is now available on prescription. Approved by the MHRA in July 2025, EURneffy® delivers a 2mg dose of adrenaline via a simple nasal spray, offering a fast, effective alternative to traditional AAIs for adults and children weighing 30kg or more. [gov.uk]
Why It Matters
- Rapid Action: Adrenaline is absorbed quickly through the nasal lining—even with congestion.
- Comparable Effectiveness: Real-world data shows EURneffy® is as effective as AAIs, with 89% of patients successfully treated with a single dose. [allergicliving.com]
- Needle-Free Confidence: Reduces hesitation and anxiety, especially in emergencies.
- Longer Shelf Life: Up to 30 months, with better temperature stability than injectors. [pharmtech.com]
Who Can Benefit?
This new option is ideal for those who:
- Struggle with needle phobia
- Need a more portable and discreet emergency treatment
- Want a reliable alternative with fewer storage concerns
Time for a Review?
If you or someone you care for is at risk of anaphylaxis, speak to your GP about whether EURneffy® is right for you. Please contact [email protected] or call 020 3955 5444 to book your allergy review